Ren Jie Jin

815 total citations
17 papers, 640 citations indexed

About

Ren Jie Jin is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Ren Jie Jin has authored 17 papers receiving a total of 640 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 5 papers in Molecular Biology and 3 papers in Oncology. Recurrent topics in Ren Jie Jin's work include Prostate Cancer Treatment and Research (6 papers), Sperm and Testicular Function (2 papers) and Prostate Cancer Diagnosis and Treatment (2 papers). Ren Jie Jin is often cited by papers focused on Prostate Cancer Treatment and Research (6 papers), Sperm and Testicular Function (2 papers) and Prostate Cancer Diagnosis and Treatment (2 papers). Ren Jie Jin collaborates with scholars based in United States, South Korea and China. Ren Jie Jin's co-authors include Robert J. Matusik, Xiuping Yu, Yongqing Wang, Simon W. Hayward, Cheol Kwak, Magdalena M. Grabowska, Sang Eun Lee, Thomas C. Case, David J. DeGraff and Zhenbang Chen and has published in prestigious journals such as Cancer Research, Cancer Letters and Cancer and Metastasis Reviews.

In The Last Decade

Ren Jie Jin

15 papers receiving 635 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ren Jie Jin United States 12 339 298 180 178 98 17 640
Mathew J. Putzi United States 11 295 0.9× 307 1.0× 198 1.1× 156 0.9× 221 2.3× 16 796
Lixun Chai China 5 271 0.8× 243 0.8× 162 0.9× 95 0.5× 76 0.8× 6 530
Andrew Trotta Australia 13 453 1.3× 122 0.4× 125 0.7× 154 0.9× 84 0.9× 17 693
Zhaomei Zhang United States 12 239 0.7× 118 0.4× 100 0.6× 93 0.5× 58 0.6× 13 548
Suping Guo China 20 498 1.5× 213 0.7× 275 1.5× 246 1.4× 39 0.4× 65 977
Xiuzhi Duan China 13 264 0.8× 109 0.4× 99 0.6× 130 0.7× 52 0.5× 33 526
Juanjie Bo China 14 375 1.1× 120 0.4× 176 1.0× 200 1.1× 17 0.2× 24 679
Mingbo Cao China 7 205 0.6× 140 0.5× 140 0.8× 104 0.6× 27 0.3× 14 430
Keshab R. Parajuli United States 11 243 0.7× 62 0.2× 153 0.8× 98 0.6× 51 0.5× 22 503

Countries citing papers authored by Ren Jie Jin

Since Specialization
Citations

This map shows the geographic impact of Ren Jie Jin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ren Jie Jin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ren Jie Jin more than expected).

Fields of papers citing papers by Ren Jie Jin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ren Jie Jin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ren Jie Jin. The network helps show where Ren Jie Jin may publish in the future.

Co-authorship network of co-authors of Ren Jie Jin

This figure shows the co-authorship network connecting the top 25 collaborators of Ren Jie Jin. A scholar is included among the top collaborators of Ren Jie Jin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ren Jie Jin. Ren Jie Jin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Shu, Yilai, Zhongli Wang, Fang Shen, et al.. (2025). The impact of high-frequency rTMS treatment on brain activity in PSCI patients: a TMS-EEG study. Frontiers in Neurology. 16. 1582437–1582437.
2.
Dai, Huijun, Jifeng Feng, Lijuan Wei, et al.. (2021). Morphine may act via DDX49 to inhibit hepatocellular carcinoma cell growth. Aging. 13(9). 12766–12779. 9 indexed citations
3.
Jiang, Li, et al.. (2020). Study on risk factors, bacterial species, and drug resistance of acute pyelonephritis associated with ureteral stent after percutaneous nephrolithotomy. European Journal of Clinical Microbiology & Infectious Diseases. 40(4). 707–713. 3 indexed citations
4.
Strand, Douglas W., Omar E. Franco, Magdalena M. Grabowska, et al.. (2016). NF‐κB and androgen receptor variant 7 induce expression of SRD5A isoforms and confer 5ARI resistance. The Prostate. 76(11). 1004–1018. 20 indexed citations
5.
Strand, Douglas W., Omar E. Franco, Magdalena M. Grabowska, et al.. (2015). NF‐κB and androgen receptor variant expression correlate with human BPH progression. The Prostate. 76(5). 491–511. 48 indexed citations
6.
Grabowska, Magdalena M., David J. DeGraff, Xiuping Yu, et al.. (2014). Mouse models of prostate cancer: picking the best model for the question. Cancer and Metastasis Reviews. 33(2-3). 377–397. 89 indexed citations
7.
Jin, Ren Jie, Linda Connelly, Yongqing Wang, et al.. (2008). The Nuclear Factor-κB Pathway Controls the Progression of Prostate Cancer to Androgen-Independent Growth. Cancer Research. 68(16). 6762–6769. 154 indexed citations
8.
Matusik, Robert J., Ren Jie Jin, Qian Sun, et al.. (2008). Prostate epithelial cell fate. Differentiation. 76(6). 682–698. 30 indexed citations
9.
Jin, Ren Jie, Yongqing Wang, Mingfang Ao, et al.. (2008). Down-regulation of p57Kip2 Induces Prostate Cancer in the Mouse. Cancer Research. 68(10). 3601–3608. 30 indexed citations
10.
Wang, Yongqing, Siegfried Kasper, Jialing Yuan, et al.. (2006). Androgen-dependent prostate epithelial cell selection by targeting ARR2PBneo to the LPB-Tag model of prostate cancer. Laboratory Investigation. 86(10). 1074–1088. 11 indexed citations
11.
Chung, Jinsoo, et al.. (2004). Enhanced chemosensitivity of bladder cancer cells to cisplatin by suppression of clusterin in vitro. Cancer Letters. 203(2). 155–161. 33 indexed citations
12.
Huang, Xiaojing & Ren Jie Jin. (2004). Complementary-code-division multiplexing for future generation WLAN and mobile communicatrions. UTS ePRESS (University of Technology Sydney). 4 indexed citations
13.
Jin, Ren Jie, Yongqing Wang, Naoya Masumori, et al.. (2004). NE-10 Neuroendocrine Cancer Promotes the LNCaP Xenograft Growth in Castrated Mice. Cancer Research. 64(15). 5489–5495. 92 indexed citations
14.
Jin, Ren Jie, Cheol Kwak, Hyeon Jeong, et al.. (2002). Suppression of clusterin expression enhanced cisplatin-induced cytotoxicity on renal cell carcinoma cells. Urology. 60(3). 516–520. 24 indexed citations
15.
Jin, Ren Jie, et al.. (2000). The application of an antiangiogenic gene (thrombospondin-1) in the treatment of human prostate cancer xenografts. Cancer Gene Therapy. 7(12). 1537–1542. 61 indexed citations
16.
Lee, Sang Eun, Ren Jie Jin, Sang Goo Lee, et al.. (2000). Development of a new plasmid vector with PSA-promoter and enhancer expressing tissue-specificity in prostate carcinoma cell lines.. PubMed. 20(1A). 417–22. 32 indexed citations
17.
Lai, Xinsheng, et al.. (1999). The effect of electroacupuncture on auditory P300 potential in mongolism cases.. PubMed. 19(4). 259–63.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026